Researcher

Sophie Bellanger obtained her PhD degree from the Pasteur Institute in Paris, France, where she uncovered how a human papillomavirus (HPV) protein induces chromosomal instability and thus contributes to HPV infection-related cancers. She joined the Institute of Medical Biology (IMB), A*STAR, in 2006 as a Research Fellow and was promoted to Research Scientist in 2010 to lead HPV projects related to cell cycle checkpoints, metabolism and apoptosis. In 2013, she was appointed as an independent Project Leader to work on skin stem cells, and she is now a Principal Investigator at the Skin Research Institute of Singapore (SRIS). Her team investigates how human epidermal stem cells transit from proliferation to differentiation, with a focus on cell cycle, metabolism and aging regulation.